Activation of the mucosal immune system in irritable bowel syndrome

Gastroenterology - Tập 122 - Trang 1778-1783 - 2002
Vinton S. Chadwick1, Wangxue Chen1, Dairu Shu1, Barbara Paulus1, Peter Bethwaite2, Andy Tie2, Ian Wilson1
1Wakefield Gastroenterology Centre and Research Institute, Wakefield Hospital
2Medical Laboratory Wellington, Wellington, New Zealand

Tài liệu tham khảo

Hasler, 1995, Irritable bowel syndrome, Curr Opin Gastroenterol, 11, 16, 10.1097/00001574-199501000-00005 Drossman, 1990, Identification of sub-groups of functional gastrointestinal disorders, Gastroenterol Int, 3, 159 Thompson, 1992, Functional bowel disorders and chronic functional abdominal pain, Gastroenterol Int, 2, 75 American Gastroenterological Association medical position statement, 1997, irritable bowel syndrome, Gastroenterology, 112, 2118, 10.1053/gast.1997.1122118 Kellow, 1988, Dysmotility of the small intestine in irritable bowel syndrome, Gut, 29, 1236, 10.1136/gut.29.9.1236 Mertz, 1995, Altered rectal perception is a biological marker of patients with irritable bowel syndrome [published erratum appears in Gastroenterology 1997;113:1054], Gastroenterology, 109, 40, 10.1016/0016-5085(95)90267-8 Salzmann, 1989, Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases, Lab Invest, 60, 847 Lee, 1988, Quantification of colonic lamina propria cells by means of a morphometric point-counting method, Gastroenterology, 94, 409, 10.1016/0016-5085(88)90430-1 Hiatt, 1962, Mast cells in inflammatory conditions of the gastrointestinal tract, Am J Gastroenterol, 37, 541 Weston, 1993, Terminal ileal mucosal mast cells in irritable bowel syndrome, Dig Dis Sci, 38, 1590, 10.1007/BF01303164 O'Sullivan, 2000, Increased mast cells in the irritable bowel syndrome, Neurogastroenterol Motil, 12, 449, 10.1046/j.1365-2982.2000.00221.x Gwee, 1999, The role of psychological and biological factors in postinfective gut dysfunction, Gut, 44, 400, 10.1136/gut.44.3.400 Spiller, 2000, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome, Gut, 47, 804, 10.1136/gut.47.6.804 Veress, 1995, Microscopic colitis syndrome [see comments], Gut, 36, 880, 10.1136/gut.36.6.880 Chadwick, 1990, Measurements of unsaturated vitamin B12-binding capacity and myeloperoxidase as indices of severity of acute inflammation in serial colonoscopy biopsy specimens from patients with inflammatory bowel disease, Scand J Gastroenterol, 25, 1196, 10.3109/00365529008998554 Schlup, 1993, Potential of measurements of unsaturated vitamin B12-binding capacity in serial colonoscopic biopsy specimens for global and regional assessments of disease severity in inflammatory bowel disease, Scand J Gastroenterol, 28, 1005, 10.3109/00365529309098300 Groux, 2001, An overview of regulatory T cells, Microbes Infect, 3, 883, 10.1016/S1286-4579(01)01448-4 Collins, 1992, Is the irritable gut an inflamed gut?, Scand J Gastroenterol Suppl, 192, 102, 10.3109/00365529209095988 Collins, 1999, Stress, inflammation and the irritable bowel syndrome, Can J Gastroenterol, 13, 47A, 10.1155/1999/916075 Driman, 1998, Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution, Hum Pathol, 29, 972, 10.1016/S0046-8177(98)90203-9 Bueno, 1999, Effects of inflammatory mediators on gut sensitivity, Can J Gastroenterol, 13, 42A, 10.1155/1999/846809